CAPITOL COUNSEL LLC for ASTRAZENECA PHARMACEUTICALS, LP
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care reform; Federal Food, Drug and Cosmetic Act Issues, including drug safety and comparative effectiveness, follow-on biologics and related provisions in HR 1956, Patient Protection and Innovative Biologic Medicines Act, HR 5629, Pathway for Biosimilars Act, and S. 1695, Biologics Price Competition and Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| JAMES GOULD | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JOHN D RAFFAELLI | — |
| RICHARD LYLES SULLIVAN | — |
Medicare/Medicaid MMM
Medicare Medicaid coverage, coding and reimbursement of pharmaceuticals, including policies for budesonide inhalation therapies; Medicaid prescription drug rebate and possible related provisions in S. 3101 and HR 6133, Medicare Improvements for Patients and Providers Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| JAMES GOULD | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JOHN D RAFFAELLI | — |
| RICHARD LYLES SULLIVAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.